NEW YORK (GenomeWeb News) – OriGene Technologies announced that it has received a contract from the National Cancer Institute to develop high affinity anti-peptide antibodies for SISCAPA assays.
Registering provides access to this and other free content.
Already have an account?Login Now.
The New York Times reports that as China invests in science, it also is dealing with research fraud.
In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.
Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.
The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.